Staff in the School of Cancer Sciences

 

Dr Ayman Antoun

Dr Ayman Antoun

Research Fellow

Ayman Antoun obtained his PhD and Licenciate in Cell and Molecular Biology from Uppsala University, Sweden in 2003, and his BSc (Hons) in Pharmacy from University of Cairo in 1997.

Ayman is a Research Fellow in the School of Cancer Sciences, College of Medical and Dental Sciences.

Ayman has published research papers in scientific journals as EMBO J. ...

Dr Jean Assender

Dr Jean Assender

Lecturer in Cancer Sciences

Jean Assender is a Lecturer in Cancer Sciences with an interest in breast cancer.

She is the College Head of Quality Assurance and Enhancement for postgraduate taught programmes and frequently chairs University appeals hearings.

As Programme Lead for the MSc in Clinical Oncology she has increased the scope of the programme introducing new modules, an FRCR route and now ...

Mr Andrew D Beggs

Mr Andrew D Beggs

Clinical Lecturer in General Surgery

Andrew Beggs is a Clinical Lecturer in General Surgery in the School of Cancer Sciences, University of Birmingham.

His major research interests include colorectal cancer biology and he has published articles in The Lancet, Gut, Journal of Pathology and PLoS Genetics. He collaborated in writing the European consensus guidelines for the management of Peutz-Jeghers syndrome.
...

Dr Andrew Bell

Dr Andrew Bell

Research Fellow

Dr Andrew Bell is a Research Fellow in the Department of Cancer Studies. His research focuses on the biology of Epstein-Barr virus, a widespread herpes virus associated with a number of human malignancies. He works closely with Prof. Martin Rowe and Prof. Alan Rickinson, and his work is funded by several grants from Cancer Research UK.

Prof Lucinda Billingham

Prof Lucinda Billingham

Professor of Biostatistics, School of Cancer Sciences
Biostatistics Lead and Assistant Director, Cancer Research UK Clinical Trials Unit

Lucinda Billingham is Professor of Biostatistics within the School of Cancer Sciences and the School of Health and Population Sciences at the University of Birmingham. She is Biostatistics Lead and Assistant Director at the Cancer Research UK Clinical Trials Unit at Birmingham which runs an extensive portfolio of phase I to III clinical trials. She is also the Director of the MRC Midland Hub for ...

Professor David Blackbourn

Professor David Blackbourn

Professor of Virology

David Blackbourn is Professor of Virology in the College of Medical and Dental Sciences at the University of Birmingham. His group studies viruses that are responsible for causing cancer. In particular, his interests lie in how such viruses cause disease and how they evade the immune response. 

Prof Blackbourn has published over 60 research papers and reviews in ...

Professor Constanze Bonifer

Professor Constanze Bonifer

Chair of Experimental Haematology

Constanze is a professor within the School of Cancer Sciences and has spent her career engaged in research in the field of gene regulation in the hematopoietic system. Constanze recently moved the University of Birmingham from the University of Leeds.

Constanze has published more than 80 papers in the field of gene regulation and holds programme grants from the BBSRC and Leukaemia ...

Mrs Elizabeth Brettell

Mrs Elizabeth Brettell

Elizabeth Brettell is the Renal Trials Portfolio Manager at the Birmingham Clinical Trials Unit (BCTU).
Elizabeth has worked at BCTU since 1998 co-ordinating large randomised controlled clinical trials in Alzheimer’s Disease, Acute Myeloid Leukaemia, women’s health and renal disease.

Dr Victoria Brookes

Clinical Trial Co-ordinator

Dr Brookes is an historian by training. Having spent most of her academic life studying in the North West she returned to her home city of Birmingham where she became involved in medical research. She lives with her partner Martyn and their goldfish!

Dr Richard Bryan

Dr Richard Bryan

Senior Research Fellow

Rik Bryan qualified in Medicine at the University of Birmingham and subsequently entered surgical training. After completing a PhD in bladder cancer biology he became a Specialist Registrar in Urology. After 3-years as a Specialist Registrar, Rik left clinical urology to assist with the set-up of the Bladder Cancer Prognosis Programme in the Department of Public Health, Epidemiology and ...